Posts tagged “GSK”
Having been fined nearly $500 million in China for bribery, facing investigations in other countries and battling lagging revenue, GSK now faces more cost cuts and is contemplating a stock offering for its ViiV Healthcare. But GSK's CEO Andrew Witty defended himself and his strategy in discussing the drug giant's most recent quarterly earnings report on Wednesday. "Look at what we're able to achieve," he says.
Tens of thousands of doses of experimental Ebola vaccines -including one from GlaxoSmithKline - could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe, a top World Health Organization official said Tuesday.
The head of Ebola vaccine research at GlaxoSmithKline tells the BBC that the company's treatment that is now being tested isn't likely to be "the primary answer to this particular outbreak." He concedes GSK could have moved faster.
Lenovo class-action suit; new GSK probe; AT&T data breach; Salix drug wins OK; Facebook's anonymous app; Lenovo-NEC deal
In today's Bulldog blog wrapping up the latest technology and life science news: Lenovo settles a class-action suit over Wi-Fi; GSK faces another bribery investigation; AT&T data breach; FDA OKs Salix colitis treatment; Facebook is developing an app for anonymous posts; and Lenovo extends its partnership with NEC.
President Obama's BRAIN Initiative - Brain Research through Advancing Innovative Neurotechnologies - second year kickoff includes three RTP connections: Funding from GlaxoSmithKline and research grants for teams at UNC-Chapel Hill as well as Duke.
Drug giant GlaxoSmithKline will have a new chairman a year from now: Philip Hampton, the current chair at Royal Bank of Scotland Group. Hampton will first join the GSK board as of Jan. 1 as a director.
New GSK chairman; Lenovo stock pressure; FTC bitcoin crackdown; FAA to OK drones; Cree's new competition
In today's wrapup of life science and technology news: GSK is getting a new chairman in wake of the China bribery scandal, says The Times of London; Lenovo stock faces price pressure; FTC takes aim at bitcoins; FAA to OK drones for Hollywood; Cree's new competition from Philips.
Through its GSK China website, the drug giant formally apologized to the Chinese government and people for "illegal activities" that led to a $492 million fine and conviction of its top executive in that country. The full statement follows.
The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. Beginning Tuesday, it will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems.
A possible vaccine to treat the spreading Ebola outbreak in Africa could be coming from GSK. Plus, a lab in Greenville could be a site where a treatment is produced.
As more companies step up efforts to develop vaccines targeting ebola and the disease outbreak spreads in Africa, a doctor at Duke University warns that using untested drugs "could prove disastrous."
Another day, another headache in the global press for GlaxoSmithKline and its CEO Andrew Witty. This time it's an in-depth report in The Wall Street Journal in which some investors question Witty's performance as the drug giant fights lagging sales and scandal.
A World Health Organization official says the first ebola vaccine could be available in 2015. It's being developed by GlaxoSmithKline. However, the drug giant says "it's too early" to speculate on timing.
"The root of the problem really from where I'm sitting is the way GSK behaved in this matter," the son of convicted investigator tells London-based broadcaster Sky News. GSK has said it hired the couple to investigate a security breach but not bribery allegations.
Peter Humphrey and Yingzeng Yu worked under contract for British pharmaceutical giant GlaxoSmithKline, which is accused in a separate case of bribing Chinese doctors and hospitals to use its products. Authorities have not indicated whether these two cases are linked as the fraud trial continues in China.
In the latest Bulldog roundup of life science and technology news: GSK gets a lift as Express Scripts reinstates lung drug Advair; Comcast initiates amnesty, free service for the poor; FCC's Friends and Family Plan; and Wikipedia link to be hidden in Google under 'right to be forgotten' law.
In the latest Bulldog roundup of life science and technology news: The real difference between Microsoft and Apple; Novo Nordisk leapfrogs Glaxo as U.K. drug giant declines; U.S. Map shows more community-owned broadband networks than expected; Google email scan leads to sex offender arrest; and Metrics Contract Services adopt new name and logo.
The experimental shot is the most advanced candidate vaccine for malaria but results from previous trials have been disappointing. Research published in 2012 showed the shot only reduced malaria cases by about 30 percent in babies aged six to 12 weeks, the target age for immunization.